Gamma interferon protects mice from Ebola 19 November 2015 | By Victoria White A new study suggests that gamma interferon, which is an FDA-approved drug, may have potential as an antiviral therapy to prevent Ebola infection when given either before or after exposure to the virus...
York scientists reveal structure of heparanase 19 November 2015 | By Victoria White Researchers have unveiled the 3-D structure of human heparanase - a sugar-degrading enzyme which has received significant attention as a key target in anti-cancer treatments...
‘Good’ mosquito virus could hold the key to fighting disease 18 November 2015 | By Victoria White The newly discovered virus, known as Parramatta River virus, infects only mosquitoes and does not pose any direct health risks to people...
miR-124 reduces tumour growth in advanced prostate cancer 18 November 2015 | By Victoria White miR-124 hit multiple targets, reducing androgen receptor signalling and reviving the potency of advanced prostate cancer treatment Xtandi (enzalutamide)...
TSRI scientists use trait of anti-HIV antibodies to develop vaccine candidates 18 November 2015 | By Victoria White When studying prototype antibodies that target a specific weak spot on HIV, the researchers noted two of the antibodies had an unusual feature that could prove important in vaccine design...
Morphotek and Univeristy of Gothenburg to develop farletuzumab 18 November 2015 | By Victoria White Morphotek and the TAT Group will investigate farletuzumab as an alpha therapy vector for radioimmunotherapy in ovarian cancer...
DBV Technologies presents data on its Viaskin technology in RSV 18 November 2015 | By Victoria White DBV Tecnologies observed an immunogenic response in mice and swine treated with Viaskin with a patented formulation containing an N-FsII antigen...
UCLA researchers identify drug that helps fight side effect of ovarian cancer 17 November 2015 | By Victoria White The researchers found that a drug that inhibits a receptor called the Colony-Stimulating-Factor-1 Receptor reduces ascites with minimal side effects...
Topical formulation MGB-BP-3 completes feasibility study 17 November 2015 | By Victoria White The study showed that two preliminary topical formulations of MGB-BP-3 were successful in killing approximately 60% of MRSA in a skin infection model...
Duchenne muscular dystrophy identified as a stem cell disease 17 November 2015 | By Victoria White A new study is the first to show that Duchenne muscular dystrophy directly affects muscle stem cells...
TIGIT identified as new target for immuno-oncology therapies 17 November 2015 | By Victoria White Antibodies against TIGIT could improve the function of the DNAM-1 protein, thereby improving the ability of natural killer cells to destroy tumour cells...
Crucial cause of eczema during childhood discovered 17 November 2015 | By Victoria White Researchers have discovered that butyrate, a short-chain fatty acid (SCFA) produced by bacteria in the intestine, plays a crucial role in the development of infant eczema...
Potential target for reducing obesity-related inflammation 16 November 2015 | By Victoria White Investigators found that a protein called SIRT3 provides resistance to obesity-related inflammatory response...
Scientists use light to treat Alzheimer’s disease 16 November 2015 | By Victoria White Scientists have conducted research to suppress an abnormal assembly of beta-amyloids by using photo-excited porphyrins...
Chemists turn bacterial molecules into potential drug molecules 16 November 2015 | By Victoria White Researchers have created molecules that mimic and dominate toxic ones secreted by bacteria. The implications for the study of biology and pharmacology are said to be enormous...
